【摘要】 目的 觀察腹腔鏡手術聯(lián)合孕三烯酮治療子宮內膜異位癥合并不孕的療效及不同評分系統(tǒng)對妊娠結局的預測價值。 方法 回顧性分析2004年1月-2006年12月收治的97例子宮內膜異位癥合并不孕患者的臨床病理資料，統(tǒng)計其術后妊娠率及活產(chǎn)率。 結果 術后1年內與1~2年的妊娠率與活產(chǎn)率比較，差異均無統(tǒng)計學意義（Pgt;0.05）。根據(jù)美國生育協(xié)會1985年修訂的子宮內膜異位癥分期標準（r-AFS）進行分期，各期患者術后妊娠率差異無統(tǒng)計學意義（Pgt;0.05）；但隨著分期升高，活產(chǎn)率逐漸下降（Plt;0.05）。子宮內膜異位癥生育指數(shù)（EFI）評分越高，其妊娠率和活產(chǎn)率也越高（Plt;0.05）?！〗Y論 子宮內膜異位癥患者腹腔鏡手術后聯(lián)用孕三烯酮可能會提高遠期妊娠率。r-AFS分期對妊娠結局的預測有一定局限性，而EFI具有較好的預測性?！続bstract】 Objective To evaluate the therapeutic effectiveness of laparoscopic surgery combined with gestrinone treatment in the infertile women with endometriosis (EM), and the value of different score systems to predict gestational outcome. Methods We retrospectively analyzed the clinical data of 97 infertile women with EM who were treated in our hospital from January 2004 to December 2006, and collected their pregnancy rate (PR) and live birth rate (LBR) after operation. Results There was no significant difference of PR and LBR within the 1st year and between the 1st and the 2nd year (Pgt;0.05). There was no significant difference of PR among women of various stages of EM based on the 1985 edition of risk stratification for patients with EM put forward by American Fertility Society (r-AFS) (Pgt;0.05), but the LBR decreased with the raising of the stages (Plt;0.05). The endometriosis fertility index (EFI) was positively correlated with PR and LBR (Plt;0.05). Conclusion Laparoscopic surgery combined with gestrinone may increase the long-term pregnancy rate of women with EM. R-AFS classification is limited in predicting the gestational outcome of women with EM, while EFI achieves a better result.